Global Anemia Drug Market to Reach USD 16.2 Billion by 2032, Growing at 6.5% CAGR
The global Anemia Drug market is witnessing significant growth due to the increasing prevalence of anemia, growing geriatric population, and rising awareness about iron deficiency and related disorders. Valued at USD 9.3 billion in 2023, the market is projected to reach USD 16.2 billion by 2032, registering a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2024 to 2032. Key factors driving this growth include advancements in drug formulations, increasing demand for iron supplements, and the rising burden of chronic diseases such as kidney failure and cancer, which contribute to anemia incidence.
Read More -> https://marketintelo.com/report/anemia-drug-market
